top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
55150-0210-10 | J0583 | INJECTION, BIVALIRUDIN, 1 MG | BIVALIRUDIN (SINGLE-USE VIAL) 250 MG | IV |
55150-0212-01 | J2501 | INJECTION, PARICALCITOL, 1 MCG | PARICALCITOL (LATEX-FREE) 0.002 MG/1 ML | IV |
55150-0213-01 | J2501 | INJECTION, PARICALCITOL, 1 MCG | PARICALCITOL (LATEX-FREE) 0.005 MG/1 ML | IV |
55150-0215-02 | J2501 | INJECTION, PARICALCITOL, 1 MCG | PARICALCITOL (LATEX-FREE) 0.005 MG/1 ML | IV |
55150-0218-99 | J1327 | INJECTION, EPTIFIBATIDE, 5 MG | EPTIFIBATIDE (PF,LATEX-FREE) 0.75 MG/1 ML | IV |
55150-0219-10 | J1327 | INJECTION, EPTIFIBATIDE, 5 MG | EPTIFIBATIDE (PF,LATEX-FREE) 2 MG/1 ML | IV |
55150-0220-99 | J1327 | INJECTION, EPTIFIBATIDE, 5 MG | EPTIFIBATIDE (PF,LATEX-FREE) 2 MG/1 ML | IV |
55150-0223-10 | J2800 | INJECTION, METHOCARBAMOL, UP TO 10 ML | METHOCARBAMOL (LATEX-FREE) 100 MG/1 ML | IJ |
55150-0228-10 | J3243 | INJECTION, TIGECYCLINE, 1 MG | TIGECYCLINE (PF,LATEX-FREE) 50 MG | IV |
55150-0230-10 | J1652 | INJECTION, FONDAPARINUX SODIUM, 0.5 MG | FONDAPARINUX SODIUM (PF) 2.5 MG/0.5 ML | SC |
55150-0231-10 | J1652 | INJECTION, FONDAPARINUX SODIUM, 0.5 MG | FONDAPARINUX SODIUM (PF) 5 MG/0.4 ML | SC |
55150-0232-10 | J1652 | INJECTION, FONDAPARINUX SODIUM, 0.5 MG | FONDAPARINUX SODIUM (PF) 7.5 MG/0.6 ML | SC |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
